ストックスクリーナーアプリを入手
16.62
0.18%
-0.03
アフターアワーズ：
17.36
0.74
+4.45%
前日終値:
$16.65
開ける：
$16.71
24時間の取引高:
4.73M
Relative Volume:
0.48
時価総額：
$8.58B
収益：
$11.24B
当期純損益:
$-900.00M
株価収益率:
-9.8987
EPS:
-1.679
ネットキャッシュフロー:
$323.00M
1週間 パフォーマンス:
-1.07%
1か月 パフォーマンス:
-6.05%
6か月 パフォーマンス:
-27.42%
1年 パフォーマンス:
-41.97%
1日の値動き範囲:
$16.38
$16.80
1週間の範囲:
$16.31
$17.20
52週間の値動き範囲:
$15.73
$32.68
Baxter International Inc Stock (BAX) Company Profile
名前
Baxter International Inc
セクター
電話
(224) 948-2000
住所
ONE BAXTER PARKWAY, DEERFIELD, IL
Compare BAX vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
16.62 | 8.60B | 11.24B | -900.00M | 323.00M | -1.679 |
ISRG
Intuitive Surgical Inc
|
452.95 | 160.74B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
154.96 | 44.18B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
74.67 | 36.38B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
43.12 | 35.62B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.05 | 32.77B | 5.40B | 1.49B | 1.78B | 10.12 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-31 | ダウングレード | Argus | Buy → Hold |
| 2025-08-04 | ダウングレード | Stifel | Buy → Hold |
| 2025-08-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-02-26 | 再開されました | Goldman | Buy |
| 2025-02-24 | アップグレード | Argus | Hold → Buy |
| 2025-02-20 | 再開されました | Barclays | Overweight |
| 2024-07-15 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | 開始されました | Goldman | Neutral |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-01-06 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-12-19 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-12-15 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-12-12 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-06-24 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | ダウングレード | Goldman | Neutral → Sell |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-18 | 繰り返されました | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | 繰り返されました | Morgan Stanley | Overweight |
| 2022-02-18 | 繰り返されました | Raymond James | Outperform |
| 2022-02-18 | 繰り返されました | Stifel | Buy |
| 2022-02-18 | 繰り返されました | UBS | Neutral |
| 2022-02-18 | 繰り返されました | Wells Fargo | Overweight |
| 2022-02-11 | 開始されました | Goldman | Neutral |
| 2022-01-07 | 再開されました | Citigroup | Buy |
| 2022-01-07 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | アップグレード | Cowen | Market Perform → Outperform |
| 2021-09-03 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-01-29 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | ダウングレード | UBS | Buy → Neutral |
| 2020-12-15 | ダウングレード | Goldman | Buy → Neutral |
| 2020-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2020-09-04 | ダウングレード | Argus | Buy → Hold |
| 2020-06-24 | 開始されました | Oppenheimer | Outperform |
| 2020-03-19 | アップグレード | Stifel | Hold → Buy |
| 2020-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-13 | 開始されました | Goldman | Buy |
| 2020-01-02 | アップグレード | Evercore ISI | In-line → Outperform |
| 2019-12-17 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-01-02 | アップグレード | Citigroup | Neutral → Buy |
| 2019-01-02 | アップグレード | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | アップグレード | Argus | Hold → Buy |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-05-17 | 再開されました | Piper Jaffray | Overweight |
| 2018-02-06 | 繰り返されました | Citigroup | Neutral |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2018-01-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
すべてを表示
Baxter International Inc (BAX) 最新ニュース
Fund Update: 3,614,465 BAXTER INTERNATIONAL (BAX) shares added to GREENHAVEN ASSOCIATES INC portfolio - Quiver Quantitative
Evercore ISI Group Lowers Price Target for Baxter International (BAX) to $22 | BAX Stock News - GuruFocus
Baxter Introduces the IV Verify Line Labeling System, an Automated Solution to Improve IV Labeling in Healthcare Settings - Bioscience Association Manitoba
Evercore ISI Adjusts Baxter International Price Target to $22 From $23, Maintains Outperform Rating - marketscreener.com
Evercore Maintains Baxter International Inc(BAX.US) With Buy Rating, Cuts Target Price to $22 - 富途牛牛
Assessing Baxter (BAX) Valuation After Launch Of IV Verify Line Labeling System - simplywall.st
Aug PreEarnings: Can Baxter International Inc deliver alphaEarnings Miss & Reliable Price Breakout Signals - baoquankhu1.vn
Baxter International Inc. (BAX) Stock Price, News, Quote & History - Yahoo! Finance Canada
How Investors May Respond To Baxter International (BAX) Expanding Into Automated IV Line Labeling Systems - Yahoo Finance
Does Baxter’s New IV Verify Labeling System Redefine Its Automation Edge In Healthcare Workflow Efficiency (BAX)? - simplywall.st
BAXTER INTERNATIONAL INC. R (BTL.HM) Q2 FY2025 earnings call transcript - Yahoo Finance
Baxter International unveils IV Verify to enhance IV labeling accuracy - MSN
Columbia Intrinsic Value Fund's Baxter International Inc(BAX) Holding History - GuruFocus
Baxter’s IV Verify Launch Tests Medication Safety Strategy And Hospital Traction - simplywall.st
Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch
Baxter International Introduces IV Verify to Improve the Precision of IV Labeling - Bitget
Baxter International Unveils IV Verify to Enhance IV Labeling Accuracy - Yahoo Finance
Pet Partners, Baxter Foundation Expand Therapy Animal Programs for Patients, Healthcare Workers - Pet Age
Baxter (BAX) Unveils New IV Verify Line Labeling System for Nurs - GuruFocus
Baxter International Inc. stock outperforms competitors despite losses on the day - MarketWatch
Baxter International Hits New 52-Week Low at $15.87 - Markets Mojo
Baxter International Inc (BAX) Stock Price Down 4.2% on Mar 30 - GuruFocus
Baxter launches IV labeling system aimed at improving safety, efficiency - Medical Economics
Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot - Bioscience Association Manitoba
Baxter debuts automated IV line labeling system By Investing.com - in.investing.com
Baxter debuts automated IV line labeling system - Investing.com
Baxter Foundation Therapy Animal Push And What It Means For Investors - Sahm
Baxter stock price forecast: bearish trend persists as BAX trades near 52-week lows - Traders Union
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
Baxter International (NYSE:BAX) Hits New 1-Year LowTime to Sell? - MarketBeat
Baxter International stock hits 52-week low at 16.07 USD By Investing.com - Investing.com Australia
Baxter International stock hits 52-week low at 16.07 USD - Investing.com
BAX SEC FilingsBaxter Intl Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Clinical Nutrition for Cancer Care: 2026-2030 Market - GlobeNewswire
Clinical Nutrition for Cancer Care: 2026-2030 Market Analysis Featuring Profiles of Leading PlayersAbbott Nutrition, Baxter International, B Braun Melsungen, Nestle Health Science, Danone Nutricia and More - Yahoo Finance
Bank of America maintains a hold rating on Baxter International (BAX) - MSN
Baxter International Stock: Navigating Leadership Changes and Portfolio Optimization Amid Market Pre - AD HOC NEWS
Bank of America Maintains a Hold Rating on Baxter International (BAX) - Insider Monkey
A Look At Baxter International (BAX) Valuation As CFO Transition Draws Investor Attention - simplywall.st
Baxter International Inc. stock underperforms Thursday when compared to competitors - MarketWatch
[SCHEDULE 13G/A] BAXTER INTERNATIONAL INC Amended Passive Investment Disclosure - Stock Titan
SG Americas Securities LLC Has $32.97 Million Stock Position in Baxter International Inc. $BAX - MarketBeat
Baxter to Host Annual Meeting of Stockholders in Virtual Format - marketscreener.com
Baxter investors get online-only annual meeting, with voting on May 5 - Stock Titan
Baxter International stock faces pressure from ifosfamide shortage and reduced production capacity a - AD HOC NEWS
Manufacturing Disruption Hits Baxter Cancer Drug Supply In Europe - sahmcapital.com
Therapy animals will reach 100,000 patients and care teams in pilot - Stock Titan
EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within Weeks - Benzinga
EU regulator flags Baxter cancer drug shortage until early next year - KELO-AM
Baxter International Stock Hits Day Low of $16.08 Amid Price Pressure - Markets Mojo
Baxter International Inc. stock faces pressure from EU cancer drug shortage warning until early 2027 - AD HOC NEWS
Baxter International Inc (BAX) 財務データ
収益
当期純利益
現金流量
EPS
1.20%
0.97%
大文字化:
|
ボリューム (24 時間):